Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study | Zendy

Donna O. Lowe | Zendy; M. M. Mamdani | Zendy; Alex Kopp | Zendy; Donald E. Low | Zendy; David N. Juurlink | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study

Author(s) -

Donna O. Lowe,

M. M. Mamdani,

Alex Kopp,

Donald E. Low,

David N. Juurlink

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/508453

Subject(s) - medicine , clostridium difficile , proton pump inhibitor , antibiotics , clostridium infections , intensive care medicine , clostridium , population , disease , microbiology and biotechnology , environmental health , bacteria , biology , genetics

Previous studies have examined the association between proton pump inhibitor (PPI) use and the risk of Clostridium difficile-associated disease (CDAD), with conflicting results. Whether outpatient PPI use influences the risk of hospital admission for CDAD among older patients who have recently been treated with antibiotics is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research